Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/9837

Fish Project 1 (Nitromethane): Target Organs and Levels of Evidence TR-528

Carcinogenesis Studies of 2,2-bis(Bromomethyl)-1,3-Propanediol, Nitromethane, and 1,2,3-Trichloropropane (CASRNs 3296-90-0, 75-52-5, and 96-18-4) in Guppies (Poecilia reticulata) and Medaka (Oryzias latipes) (Waterborne Studies)

Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Fish Project 1 (Nitromethane)
75-52-5
02/18/2004 Aquatic
Medaka: 9.4, 21, OR 46.6 MG/L 160 FISH/DOSE/SPECIES
Gulf Coast Research Laboratory

Levels of Evidence

Male Fish: Negative
Female Fish: Negative


Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Fish Project 1 (Nitromethane)
75-52-5
02/18/2004 Aquatic
Guppy: 10.8, 30.9, OR 88.4 MG/L 160 FISH/DOSE/SPECIES
Gulf Coast Research Laboratory

Levels of Evidence

Male Fish: Inadequate Study
Female Fish: Negative


Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Fish project 1 (2,2-bis(Bromomethyl)-1,3-propanediol)
3296-90-0
02/18/2004 Aquatic
Guppy: 160 FISH/DOSE/SPECIES
Gulf Coast Research Laboratory

Levels of Evidence

Male Fish: Positive
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Liver (Core Study): ADENOMA 3/61 4/50 4/41 8/38 ADENOMA OR CARCINOMA 4/61 6/50 6/41 10/38
  • Liver (Stop-Exposure Study): ADENOMA 0/28 3/22 3/21 6/24 ADENOMA OR CARCINOMA 0/28 3/22 3/21 9/24
Female Fish: Inadequate Study


Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Fish project 1 (2,2-bis(Bromomethyl)-1,3-propanediol)
3296-90-0
02/18/2004 Aquatic
Medaka: 0, 24, 60, 150 MG/L 160 FISH/DOSE/SPECIES
Gulf Coast Research Laboratory

Levels of Evidence

Male Fish: Positive
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Liver (Core Study): ADENOMA 1/47 0/59 0/56 6/59 ADENOMA OR CARCINOMA 1/47 0/59 0/56 8/59
  • Liver (Stop-Exposoure Study): ADENOMA 1/27 0/21 1/31 3/29 ADENOMA OR CARCINOMA 1/27 0/21 1/31 4/29
Female Fish: Negative


Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Fish project 1 (1,2,3-Trichloropropane)
96-18-4
02/18/2004 Aquatic
Guppy: 0, 4.5, 9, OR 18 MG/L (2 REPLICATES PER TREATMENT GROUP) 170 FISH/EACH REPLICATE AQUARIUM
Gulf Coast Research Laboratory

Levels of Evidence

Male Fish: Positive
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Liver (Core Study): CHOLANGIOCARCINOMA 0/61 0/47 0/67 3/27 ADENOMA 3/61 8/47 17/67 9/27 CARCINOMA 0/61 1/47 0/67 7/27 ADENOMA OR CARCINOMA COMBINED 3/61 9/47 17/67 15/27
  • Liver (Stop-Exposure Study): CHOLANGIOCARCINOMA 0/32 0/19 0/26 1/19 ADENOMA 3/32 4/19 5/26 7/19 CARCINOMA 0/32 0/19 1/26 4/19 ADENOMA OR CARCINOMA COMBINED 3/32 4/19 5/26 10/19
Female Fish: Positive
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Liver (Core Study): CHOLANGIOMA 0/64 3/64 4/47 2/33 CHOLANGIOCARCINOMA 0/64 0/64 0/47 6/33 ADENOMA OR CARCINOMA 5/64 4/64 4/47 8/33
  • Liver (Stop-Exposure Study): CHOLANGIOMA 2/31 2/31 0/31 2/27 CHOLANGIOCARCINOMA 0/31 0/31 0/31 5/27 ADENOMA OR CARCINOMA 2/31 1/31 2/31 3/27


Chemical (Study Title)
CASRN
Peer Review Date Route/Exposure Levels Study Laboratory
Fish project 1 (1,2,3-Trichloropropane)
96-18-4
02/18/2004 Aquatic
Medaka: 0, 4.5, 9, OR 18 MG/L (2 REPLICATES PER TREATMENT GROUP) 170 FISH/EACH REPLICATE AQUARIUM
Gulf Coast Research Laboratory

Levels of Evidence

Male Fish: Positive
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Liver (Core Study): CHOLANGIOMA 0/95 6/94 2/65 1/78 CHOLANGIOCARCINOMA 0/95 32/94 43/65 45/78 ADENOMA OR CARCINOMA 0/95 2/94 1/65 6/78 HEPATOCHOLANGIOCARCINOMA 0/95 0/94 2/65 6/78
  • Liver (Stop-Exposure Study): CHOLANGIOMA 0/42 0/47 3/33 1/46 CHOLANGIOCARCINOMA 0/42 19/47 16/33 26/46 ADENOMA 0/42 1/47 0/33 0/46 ADENOMA OR CARCINOMA 0/42 2/47 0/33 1/46
  • Gallbladder (Core Study): ADENOMA, PAPILLARY 0/91 0/83 4/61 9/72
  • Gallbladder (Stop-Exposure Study): ADENOMA, PAPILLARY 0/41 0/42 3/30 4/46
Female Fish: Positive
Type Organ/Tissue (Lesion)
Neoplastic Lesions
  • Liver (Core Study): CHOLANGIOCARCINOMA 0/95 29/93 53/94 41/67 ADENOMA 1/95 1/93 5/94 8/67 CARCINOMA 1/95 1/93 2/94 5/67 ADENOMA OR CARCINOMA 2/95 2/93 7/94 13/67 HEPATOCHOLANGIOCARCINOMA 0/95 0/93 4/94 7/67
  • Liver (Stop Exposure Study): CHOLANGIOCARCINOMA 1/57 15/44 31/49 21/31 ADENOMA 4/57 2/44 2/49 1/31 CARCINOMA 0/57 2/44 1/49 4/31 ADENOMA OR CARCINOMA 4/57 4/44 2/49 5/31 HEPATOCHOLANGIOCARCINOMA 0/57 0/44 0/49 1/31
  • Gallbladder (Core Study): ADENOMA, PAPILLARY 0/85 1/80 5/88 6/65
  • Gallbladder (Stop-Exposure Study): ADENOMA, PAPILLARY 0/56 1/40 1/45 1/30